CV Sciences (CVSI) Research & Development (2013 - 2026)
CV Sciences' (CVSI) quarterly Research & Development came in at $18000.0 in Q1 2026, down 40.0% year-on-year from $30000.0 in Q1 2025, and little changed quarter-over-quarter from $18000.0 in Q4 2025.
CV Sciences (CVSI) Research & Development (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Research & Development across 14 years of filings, most recently posting $18000.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $18000.0, down 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $110000.0 (up 17.02% YoY), and the FY2025 annual result was $122000.0, up 22.0% from the prior year.
- Research & Development came in at $18000.0 for Q1 2026 at CV Sciences, roughly flat from $18000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $121000.0 in Q1 2022 to a low of $7000.0 in Q4 2024.
- The 5-year median for Research & Development is $35000.0 (2023), against an average of $40647.1.
- Across the five-year window, Research & Development sank 91.29% in 2022 and surged 157.14% in 2025, its largest moves.
- CV Sciences' Research & Development stood at $33000.0 in 2022, then climbed by 21.21% to $40000.0 in 2023, then sank by 82.5% to $7000.0 in 2024, then soared by 157.14% to $18000.0 in 2025, then changed by 0.0% to $18000.0 in 2026.
- The last three Research & Development figures came in at $18000.0 (Q1 2026), $18000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 36,000.00 |
| Mar 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 44,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 225,000.00 |